WJ-39, CAS [[3009908-95-3]]

Artikelnummer: MCE-HY-162325
Artikelname: WJ-39, CAS [[3009908-95-3]]
Artikelnummer: MCE-HY-162325
Hersteller Artikelnummer: HY-162325
Alternativnummer: MCE-HY-162325-50MG,MCE-HY-162325-100MG,MCE-HY-162325-5MG,MCE-HY-162325-10MG,MCE-HY-162325-25MG,MCE-HY-162325-10MMX1ML
Hersteller: MedchemExpress
Kategorie: Biochemikalien
WJ-39 is an orally active aldose reductase (AR) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis[1].
Molekulargewicht: 430.32
Reinheit: 99.60
CAS Nummer: [3009908-95-3]
Formel: C19H14Cl2KNO4
Target-Kategorie: Aldose Reductase,Apoptosis,Mitochondrial Metabolism,Mitophagy
Anwendungsbeschreibung: MCE Product type: Reference compound